×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Skin Cancer
Kristie L. Kahl
In this week’s episode of “CURE Talks Cancer,” we spoke with a melanoma survivor who wishes she knew at diagnosis what her cancer journey would do for her – not to her.
Barbara Tako
A nine-year breast cancer survivor and five-year melanoma survivor shares her thoughts on cancer survivorship with a side of mid-life crisis.
Beth Fand Incollingo
In a talk to people affected by melanoma, Michael McGrady described reassessing his values after cancer and how it changed the course of his life.
Beth Fand Incollingo
Following surgery with medication, combining immunotherapies or targeted drugs and adding radiation to immunotherapy can improve effectiveness in treating various stages of melanoma.
Beth Fand Incollingo
With greater longevity for survivors of melanoma comes the need to treat lingering side effects and monitor for cancer recurrences.
Katie Kosko
Immunotherapy may be giving hope to people living with rare skin cancer.
Brielle Benyon
The Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) – an immunotherapy agent – for the treatment of patients with resected, high-risk, stage 3 melanoma.
Barbara Tako
Here are tips for fellow cancer survivors to clear out cancer paraphernailia but keep important medical records.
Barbara Tako
Two-time cancer survivor suggests a careful approach when researching your own cancer.
Brielle Benyon
A web-based intervention may help reduce harmful UV exposure and skin cancer risk in young adults, according to recent research.